Published in J Virol on February 01, 2002
Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J Virol (2004) 2.06
Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. J Virol (2005) 1.88
Discovery of antivirals against smallpox. Proc Natl Acad Sci U S A (2004) 1.76
Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic "honeycomb" surface coat. J Cell Biol (2005) 1.73
The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J Virol (2005) 1.73
Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway. J Virol (2004) 1.62
Cryo-electron tomography of vaccinia virus. Proc Natl Acad Sci U S A (2005) 1.48
Vaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions. J Virol (2003) 1.39
Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane. J Virol (2005) 1.39
Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J Virol (2003) 1.36
Defining the cellular target(s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J Virol (2006) 1.26
Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J Virol (2005) 1.25
Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane. Proc Natl Acad Sci U S A (2006) 1.23
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. J Virol (2008) 1.22
Vimentin rearrangement during African swine fever virus infection involves retrograde transport along microtubules and phosphorylation of vimentin by calcium calmodulin kinase II. J Virol (2005) 1.17
Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J Virol (2003) 1.13
Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin. J Virol (2004) 1.12
Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assembly. BMC Mol Biol (2007) 1.11
Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J Virol (2003) 1.07
Key Golgi factors for structural and functional maturation of bunyamwera virus. J Virol (2005) 1.06
The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis. J Virol (2002) 1.04
Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions. J Virol (2009) 1.04
Reovirus forms neo-organelles for progeny particle assembly within reorganized cell membranes. MBio (2014) 1.04
Diversity and selectivity in mRNA translation on the endoplasmic reticulum. Nat Rev Mol Cell Biol (2015) 1.04
Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment. J Virol (2007) 1.02
Vaccinia virus mutants with alanine substitutions in the conserved G5R gene fail to initiate morphogenesis at the nonpermissive temperature. J Virol (2004) 1.02
Participation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions. J Virol (2011) 1.00
Noncanonical role for the host Vps4 AAA+ ATPase ESCRT protein in the formation of Tomato bushy stunt virus replicase. PLoS Pathog (2014) 1.00
Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus. Mol Cell Proteomics (2010) 1.00
Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells. J Virol (2003) 1.00
The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core. J Virol (2002) 0.99
Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein. J Virol (2013) 0.98
Membrane assembly during the infection cycle of the giant Mimivirus. PLoS Pathog (2013) 0.97
Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes. J Virol (2006) 0.94
Vaccinia virus A6 is essential for virion membrane biogenesis and localization of virion membrane proteins to sites of virion assembly. J Virol (2012) 0.93
Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro. J Virol (2008) 0.93
Co-opted oxysterol-binding ORP and VAP proteins channel sterols to RNA virus replication sites via membrane contact sites. PLoS Pathog (2014) 0.91
Vaccinia virus virion membrane biogenesis protein A11 associates with viral membranes in a manner that requires the expression of another membrane biogenesis protein, A6. J Virol (2012) 0.91
Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting protein A30.5. J Virol (2013) 0.90
Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum. J Virol (2012) 0.90
Poxvirus membrane biogenesis. Virology (2015) 0.89
Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive. Virology (2010) 0.88
Lipid membranes in poxvirus replication. Viruses (2010) 0.88
Poxvirus membrane biogenesis: rupture not disruption. Cell Microbiol (2012) 0.87
Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton. J Virol (2009) 0.86
An overview of the vaccinia virus infectome: a survey of the proteins of the poxvirus-infected cell. J Virol (2011) 0.85
Foot-and-mouth disease virus modulates cellular vimentin for virus survival. J Virol (2013) 0.85
The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus. J Virol (2011) 0.84
Vaccinia virus leads to ATG12–ATG3 conjugation and deficiency in autophagosome formation. Autophagy (2011) 0.83
Membrane association facilitates the correct processing of pp220 during production of the major matrix proteins of African swine fever virus. J Virol (2003) 0.83
Appearance of the bona fide spiral tubule of ORF virus is dependent on an intact 10-kilodalton viral protein. J Virol (2004) 0.83
Endoplasmic Reticulum: The Favorite Intracellular Niche for Viral Replication and Assembly. Viruses (2016) 0.81
The E6 protein from vaccinia virus is required for the formation of immature virions. Virology (2010) 0.81
ROCK is involved in vimentin phosphorylation and rearrangement induced by dengue virus. Cell Biochem Biophys (2013) 0.81
From crescent to mature virion: vaccinia virus assembly and maturation. Viruses (2014) 0.81
Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis. PLoS One (2010) 0.80
Vimentin mediates uptake of C3 exoenzyme. PLoS One (2014) 0.79
Open membranes are the precursors for assembly of large DNA viruses. Cell Microbiol (2013) 0.79
Surface vimentin is critical for the cell entry of SARS-CoV. J Biomed Sci (2016) 0.79
African swine fever virus protein p17 is essential for the progression of viral membrane precursors toward icosahedral intermediates. J Virol (2010) 0.77
Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cells. Toxins (Basel) (2015) 0.76
Identification of Vimentin as a Potential Therapeutic Target against HIV Infection. Viruses (2016) 0.75
Functional rafts in cell membranes. Nature (1997) 38.89
Aggresomes: a cellular response to misfolded proteins. J Cell Biol (1998) 11.24
The initiation of vaccinia infection. Virology (1960) 8.35
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol (2000) 6.47
Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs. Microbiol Mol Biol Rev (1999) 5.32
Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem (1999) 4.83
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol (1993) 4.34
Actin-based motility of vaccinia virus. Nature (1995) 4.12
Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature (1969) 3.74
Vaccinia as a model for membrane biogenesis. Virology (1968) 3.73
Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur J Cell Biol (1993) 3.46
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci U S A (1996) 3.29
Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J Virol (1992) 3.24
Vaccinia virus reexamined: development and release. Virology (1976) 3.15
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol (1994) 2.92
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J Virol (1996) 2.77
Mechanisms of viral transport in the cytoplasm. Trends Microbiol (2000) 2.63
Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J Cell Biol (1998) 2.44
The Sar1 GTPase coordinates biosynthetic cargo selection with endoplasmic reticulum export site assembly. J Cell Biol (2001) 2.41
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells. J Virol (1999) 2.35
Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J Virol (1996) 2.30
Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol (1999) 2.24
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J Virol (2000) 2.20
Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J Virol (1994) 2.17
Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol (1998) 2.14
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol (2000) 2.08
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J Virol (2001) 1.98
Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO J (2000) 1.96
Eukaryotic type II chaperonin CCT interacts with actin through specific subunits. Nature (1999) 1.93
Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes. J Virol (1998) 1.91
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus. EMBO J (1996) 1.88
Aggresomes resemble sites specialized for virus assembly. J Cell Biol (2001) 1.87
A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proc Natl Acad Sci U S A (2000) 1.86
Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J Virol (1995) 1.85
The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol (1999) 1.82
The role of a 21-kDa viral membrane protein in the assembly of vaccinia virus from the intermediate compartment. J Biol Chem (1996) 1.79
Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase. J Virol (1999) 1.78
Surfing pathogens and the lessons learned for actin polymerization. Trends Cell Biol (2001) 1.74
Inducer-dependent conditional-lethal mutant animal viruses. Proc Natl Acad Sci U S A (1991) 1.72
An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins. J Cell Biol (1999) 1.63
Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J Virol (1995) 1.62
Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment. J Virol (1997) 1.60
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology (2000) 1.56
The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology (1982) 1.55
Pathways of protein sorting and membrane traffic between the rough endoplasmic reticulum and the Golgi complex. Semin Cell Biol (1992) 1.54
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol (2000) 1.52
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles. J Virol (1998) 1.44
Macromolecular electron microscopy in the era of structural genomics. Trends Biochem Sci (2000) 1.41
Electron microscopy of cells: a new beginning for a new century. J Cell Biol (2001) 1.35
Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. J Cell Sci (1995) 1.35
Biogenesis of vaccinia: concerning the origin of the envelope phospholipids. Virology (1974) 1.29
Structure of L-A virus: a specialized compartment for the transcription and replication of double-stranded RNA. J Cell Biol (1997) 1.29
Structure of intracellular mature vaccinia virus observed by cryoelectron microscopy. J Virol (1994) 1.21
Two types of virus-related particles are found during transmissible gastroenteritis virus morphogenesis. J Virol (1998) 1.21
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
The vaccinia virus I1 protein is essential for the assembly of mature virions. J Virol (1997) 1.17
Vaccinia virions lacking core protein VP8 are deficient in early transcription. J Virol (1996) 1.15
Immunolocalization of vaccinia virus structural proteins during virion formation. Virology (1994) 1.14
Structural maturation of the transmissible gastroenteritis coronavirus. J Virol (1999) 1.13
Involvement of spicules in the formation of vaccinia virus envelopes elucidated by a conditional lethal mutant. Virology (1995) 1.11
Vaccinia virus WR gene A5L is required for morphogenesis of mature virions. J Virol (1999) 1.10
The major core protein P4a (A10L gene) of vaccinia virus is essential for correct assembly of viral DNA into the nucleoprotein complex to form immature viral particles. J Virol (2001) 1.07
The vaccinia virus 39-kDa protein forms a stable complex with the p4a/4a major core protein early in morphogenesis. Virology (1999) 1.03
The potential of cryofixation and freeze substitution: observations and theoretical considerations. J Microsc (1991) 1.02
Interaction of Theiler's virus with intermediate filaments of infected cells. J Virol (1998) 1.01
Organization of the vaccinia envelope and relationship to the structure of intracellular mature virions. Virology (1995) 1.00
Rearrangement of intermediate filament network of BHK-21 cells infected with vaccinia virus. Arch Virol (1994) 0.93
Visualization of viral assembly in the infected cell. Histol Histopathol (1999) 0.92
The fracture-flip technique reveals new structural features of the Escherichia coli cell wall. J Microsc (1998) 0.84
Freeze-fracture cytochemistry: a simplified guide and update on developments. J Microsc (1991) 0.78
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med (2008) 3.42
Detailed architecture of a DNA translocating machine: the high-resolution structure of the bacteriophage phi29 connector particle. J Mol Biol (2002) 2.75
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog (2009) 2.24
The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog (2009) 2.23
APRIL modulates B and T cell immunity. J Clin Invest (2002) 2.07
Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J Virol (2003) 1.97
[Failure of a special winter programme aimed to alleviate negative effects of winter overload on an emergency department]. Med Clin (Barc) (2008) 1.95
Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Genes Dev (2006) 1.94
The structure of native influenza virion ribonucleoproteins. Science (2012) 1.93
Structure and function of a protein folding machine: the eukaryotic cytosolic chaperonin CCT. FEBS Lett (2002) 1.92
Maturation of phage T7 involves structural modification of both shell and inner core components. EMBO J (2005) 1.89
3D structure of the influenza virus polymerase complex: localization of subunit domains. Proc Natl Acad Sci U S A (2003) 1.88
Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. EMBO J (2006) 1.81
MEL-28, a novel nuclear-envelope and kinetochore protein essential for zygotic nuclear-envelope assembly in C. elegans. Curr Biol (2006) 1.74
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC. J Virol (2007) 1.68
The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res (2009) 1.67
Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J Virol (2004) 1.65
Structure of the connector of bacteriophage T7 at 8A resolution: structural homologies of a basic component of a DNA translocating machinery. J Mol Biol (2005) 1.63
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer. Curr Gene Ther (2008) 1.57
Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog (2008) 1.57
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci U S A (2011) 1.55
ISG15 regulates peritoneal macrophages functionality against viral infection. PLoS Pathog (2013) 1.51
Cryo-electron tomography of vaccinia virus. Proc Natl Acad Sci U S A (2005) 1.48
Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium. PLoS One (2012) 1.43
Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT. EMBO J (2002) 1.42
TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol (2004) 1.40
Quasi-atomic model of bacteriophage t7 procapsid shell: insights into the structure and evolution of a basic fold. Structure (2007) 1.40
Origins of phase contrast in the atomic force microscope in liquids. Proc Natl Acad Sci U S A (2009) 1.38
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C. Vaccine (2006) 1.37
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene. J Virol (2006) 1.35
Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem (2003) 1.31
Active DNA unwinding dynamics during processive DNA replication. Proc Natl Acad Sci U S A (2012) 1.30
The structure of CCT-Hsc70 NBD suggests a mechanism for Hsp70 delivery of substrates to the chaperonin. Nat Struct Mol Biol (2008) 1.29
Infectious bursal disease virus is an icosahedral polyploid dsRNA virus. Proc Natl Acad Sci U S A (2009) 1.26
Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. J Virol (2006) 1.26
Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology (2009) 1.26
Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions. J Gen Virol (2002) 1.26
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium. Vaccine (2008) 1.25
MVA and NYVAC as vaccines against emergent infectious diseases and cancer. Curr Gene Ther (2011) 1.24
Human cytomegalovirus final envelopment on membranes containing both trans-Golgi network and endosomal markers. Cell Microbiol (2009) 1.23
Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem (2006) 1.20
Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions. PLoS One (2010) 1.20
Recombinant poxviruses as mucosal vaccine vectors. J Gen Virol (2005) 1.19
Resistance to viral infection of super p53 mice. Oncogene (2005) 1.17
Determination of the topography and biometry of chlorosomes by atomic force microscopy. Photosynth Res (2002) 1.17
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One (2011) 1.16
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene (2002) 1.15
Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens. PLoS One (2010) 1.15
Improving the technique of vitreous cryo-sectioning for cryo-electron tomography: electrostatic charging for section attachment and implementation of an anti-contamination glove box. J Struct Biol (2009) 1.15
Poxvirus vector-based HIV vaccines. Curr Opin HIV AIDS (2010) 1.14
Structure of the complex between the cytosolic chaperonin CCT and phosducin-like protein. Proc Natl Acad Sci U S A (2004) 1.14
Structural polymorphism of the major capsid protein of a double-stranded RNA virus: an amphipathic alpha helix as a molecular switch. Structure (2005) 1.14
Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J Virol (2003) 1.13
Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties. J Am Chem Soc (2011) 1.13
The substrate recognition mechanisms in chaperonins. J Mol Recognit (2004) 1.13
The ESCRT machinery is not required for human cytomegalovirus envelopment. Cell Microbiol (2007) 1.13
Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochim Biophys Acta (2006) 1.12
Vaccinia virus induces apoptosis of infected macrophages. J Gen Virol (2002) 1.12
The nuclear interactor PYL8/RCAR3 of Fagus sylvatica FsPP2C1 is a positive regulator of abscisic acid signaling in seeds and stress. Plant Physiol (2009) 1.11
Cryo-X-ray tomography of vaccinia virus membranes and inner compartments. J Struct Biol (2009) 1.11
Infectious bursal disease virus capsid assembly and maturation by structural rearrangements of a transient molecular switch. J Virol (2007) 1.11
The inter-ring arrangement of the cytosolic chaperonin CCT. EMBO Rep (2007) 1.10
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses. PLoS One (2011) 1.10
Negative regulation of abscisic acid signaling by the Fagus sylvatica FsPP2C1 plays a role in seed dormancy regulation and promotion of seed germination. Plant Physiol (2003) 1.10
Direct measurement of phage phi29 stiffness provides evidence of internal pressure. Small (2012) 1.10
Architecture and nucleic acids recognition mechanism of the THO complex, an mRNP assembly factor. EMBO J (2012) 1.08
New type of outer membrane vesicle produced by the Gram-negative bacterium Shewanella vesiculosa M7T: implications for DNA content. Appl Environ Microbiol (2013) 1.08
A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J (2010) 1.07
A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis. Vaccine (2002) 1.06
Membrane cell fusion activity of the vaccinia virus A17-A27 protein complex. Cell Microbiol (2007) 1.06
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens. J Virol (2011) 1.06
Improved NYVAC-based vaccine vectors. PLoS One (2011) 1.04
IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. J Gen Virol (2003) 1.04
Evidence for a role of gibberellins in salicylic acid-modulated early plant responses to abiotic stress in Arabidopsis seeds. Plant Physiol (2009) 1.04
The impact of PKR activation: from neurodegeneration to cancer. FASEB J (2014) 1.04
Infectious Bursal disease virus: ribonucleoprotein complexes of a double-stranded RNA virus. J Mol Biol (2008) 1.04
The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. Virology (2004) 1.03
Molecular rearrangements involved in the capsid shell maturation of bacteriophage T7. J Biol Chem (2010) 1.02
Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice. J Gen Virol (2007) 1.02
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule. J Immunol (2004) 1.02
Antiviral action of the tumor suppressor ARF. EMBO J (2006) 1.02
Membrane vesicles: a common feature in the extracellular matter of cold-adapted antarctic bacteria. Microb Ecol (2010) 1.02
Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase. J Gen Virol (2003) 1.01
Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis. Infect Immun (2005) 1.01
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein. PLoS One (2012) 1.01
Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model. Viral Immunol (2009) 1.01
In cultured oligodendrocytes the A/B-type hnRNP CBF-A accompanies MBP mRNA bound to mRNA trafficking sequences. Mol Biol Cell (2008) 1.00
Poxvirus vectors as HIV/AIDS vaccines in humans. Hum Vaccin Immunother (2012) 1.00
The hexameric structure of a conjugative VirB4 protein ATPase provides new insights for a functional and phylogenetic relationship with DNA translocases. J Biol Chem (2012) 1.00